UNION is a privately-held pharmaceutical development company.
UNION has raised funds through non-dilutive sources, the European Investment Bank as well as through equity. Key shareholders are founders, management, family offices and private investors.
At UNION, we are committed to providing reliable and transparent information about our business, development programs and scientific results in a clear and timely manner.
For more information, please contact: